Sep
21
Pfizer Launches Review of $700 Million Media Business
Posted in: Uncategorized
NEW YORK (AdAge.com) — For the first time in more than 10 years, Pfizer is starting a review of its $700 million media business, currently handled by Aegis' Carat, according to people familiar with the situation. In March the pharma giant consolidated all media buying for its Wyeth DTC brands under Carat.
Post a Comment